 |
|
|
|||||
Tesla is recalling more than 63,000 Cybertrucks in the U.S. because the front lights are too bright, which may cause a distraction to other drivers and increase the risk of a collision. The National Highway Traffic Safety Administration said that the recall includes certain Cybertrucks with a model year between 2024 and 2026. The vehicles were made between Nov. 13, 2023, and Oct. 11, 2025, with operating software versions prior to 2025.38.3. The agency said that Tesla is not aware of any collisions, injuries, or fatalities related to the condition. Tesla, which is run by billionaire Elon Musk, is issuing a free software update to correct the issue. Earlier this month, federal regulators opened yet another investigation into Teslas self-driving feature after dozens of incidents in which the cars ran red lights or drove on the wrong side of the road, sometimes crashing into other vehicles and causing injuries. The National Highway Traffic Safety Administration said in a filing that it was looking into 58 incidents in which Teslas reportedly violated traffic safety laws while using the companys so-called Full Self-Driving mode, leading to more than a dozen crashes and fires and nearly two dozen injuries. The new probe adds to several other open investigations into Tesla technology that could upend Musks plans to turn millions of his cars already on the road into completely driverless vehicles with an over-the-air update to their software. In March, U.S. safety regulators recalled virtually all Cybertrucks on the road. The NHTSA’s recall, which covered more than 46,000 Cybertrucks, warned that an exterior panel that runs along the left and right side of the windshield can detach while driving, creating a dangerous road hazard for other drivers, increasing the risk of a crash. On Wednesday, Tesla reported a fourth straight decline in quarterly profit, even as sales rose. The automaker reported third-quarter earnings plunged 37% to $1.4 billion, or 39 cents a share, from $2.2 billion, or 62 cents a share, a year earlier. That marked the fourth quarter in a row that profit dropped. And even the revenue rise, a welcome relief from a sales plunge earlier in the year due to anti-Musk boycotts, came with a significant caveat: Customers rushed to take advantage of a $7,500 federal EV tax credit before it expired on Oct. 1, possibly stealing sales from the current quarter. Michelle Chapman, AP business writer
Category:
E-Commerce
Personalized vaccines that steer the immune system to fight unique cancer cells show promise, but another powerful way to treat cancer might be hiding in plain sight. People being treated for advanced skin and lung cancer lived longer if they had received a Moderna or Pfizer COVID-19 vaccine, according to new research published in the journal Nature. Both vaccines work using mRNA, which prompts cells to make a virus-like protein that triggers a useful immune response and teaches the body how to protect itself. When a team working to develop personalized mRNA cancer vaccines found that those vaccines were mostly effective due to the broad immune response they promptednot their custom-built naturethey decided to see how well widely available mRNA vaccines worked at the same task. The team analyzed records from almost 1,000 advanced cancer patients at Houstons MD Anderson Cancer Center, comparing outcomes between people that had received one of the two COVID-19 mRNA vaccines and those who hadnt. They found that lung cancer patients vaccinated with the Pfizer or Moderna shot lived almost twice as long after starting cancer treatment. Patients with aggressive melanoma who received an mRNA vaccine also showed improved outcomes, but people in that group lived for so long their average survival time couldnt be determined in the study. Non-mRNA vaccines like those used for the flu did not show the same positive effect. The patients with the biggest benefit were given the vaccine within 100 days of beginning the immunotherapy known as checkpoint treatment and those whose cancer looked the least likely to respond well to treatment. The research team believes that the immune response from mRNA vaccines sets up the immune system for more effective checkpoint treatment, which instructs T cells to work overtime to hunt down cancer in the body. The COVID-19 mRNA vaccine acts like a siren and activates the immune system throughout the entire body Adam Grippin, co-author and radiation oncologist at MD Anderson told Nature. … We were amazed at the results in our patients. Defunding the future Future research will continue to explore the powerful potential of mRNA vaccines to fight cancer, but the path wont be easy. Science funding in the U.S. has taken a massive hit across the board under the second Trump administration, but the situation is especially grim for mRNA research. In August, Health Secretary Robert F. Kennedy Jr. announced that the government would cancel $500 million in federal funds for mRNA vaccine research, throttling one of the most promising lanes of research with life-saving potential for everything from future pandemics to cancer and HIV. In a video explaining the decision to slash mRNA research, Kennedy announced that he believed science using mRNA poses more risks than benefits for these respiratory viruses and HHS would be moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions.” During Operation Warp Speed, the vaccine development program during Trumps first term lauded even by his critics, the president hailed Pfizers mRNA vaccine as a medical miracle. This is one of the greatest scientific accomplishments in history, Trump said at the time. Experts across the medical world agree, with epidemiologists issuing particularly dire warnings about Americas future without mRNA research. There is no upside, Harvard Professor of Epidemiology Bill Hanage said of the cuts to mRNA vaccine development. There is only downside. We would be fighting any future pandemic with one hand tied behind our back.
Category:
E-Commerce
Oil prices spiked Thursday after the U.S. announced massive new sanctions on Russia’s oil industry in an attempt to get Russian President Vladimir Putin to the negotiating table and end Moscows brutal war on Ukraine. U.S. benchmark crude jumped 5.8%, to $61.91 per barrel midday Thursday, and analysts say if the situation remains static, U.S. consumers will soon be paying more at the pump. Patrick De Haan, head of petroleum analysis for GasBuddy, said while it was difficult to predict with certainty because of the number of moving parts, consumers will likely see a bump in prices as early as next week, if not sooner. We’ll probably start to see motorists be impacted by the sanctions at the pump in the next couple days and it might take five days for that to be fully passed along, De Haan said, adding that the full impact also depends on whether the Russian or U.S. positions change. Russia will feel pressure to come to the table in light of the new developments or President Trump may react when he sees oil prices rising to levels that become uncomfortable, so I dont think this is going to be very long-lasting, De Haan said. Oil prices have been relatively low for the past few years and last week the cost for a barrel of U.S. benchmark crude fell below $57, its lowest level since early 2021. The price for a barrel of U.S. benchmark crude did rise near $79 a barrel early this year, just before President Donald Trump took office, a price not necessarily considered outrageously elevated by most analysts. The broad, extended decline in oil prices pushed the average price for a gallon of gas in the U.S. last week under $3 for the first time since December of last year, according to GasBuddy. For much of 2025, inflation has been held mostly in check, partly due to cheaper prices at the pump. However, that could change quickly as higher energy costs have a downstream effect on prices for virtually all products and services across industries. The impact to a lot of Americans is that products derived from cruel gasoline, diesel, and jet fuel are all likely to see price increases, De Haan said. The main reason oil and gas have stabilized at lower levels this year is that the group of countries that are part of the OPEC+ alliance of oil-exporting countries has continued to boost production. Earlier this month, OPEC+ leaders announced they would raise oil production by 137,000 barrels per day in November, the same amount announced for October. The group has been raising output slightly in a series of boosts all year after announcing cuts in 2023 and 2024. Russia is the leading non-OPEC member in the 22-country alliance. The group’s next meeting is scheduled for Nov. 2. The sanctions against Russian oil giants Rosneft and Lukoil follow calls from Ukrainian President Volodymyr Zelenskyy as well as bipartisan pressure on Trump to hit Russia with harder sanctions on its oil industry, the economic engine that has allowed Russia to continue to execute the grinding conflict even as it finds itself largely internationally isolated. The European Union on Thursday announced its own measures targeting Russian oil and gas. The price for Brent crude, the international standard, rose $3.26 on Thursday to $65.85 per barrel. Matt Ott, Associated Press business writer
Category:
E-Commerce
All news |
||||||||||||||||||
|
||||||||||||||||||